Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    PHARMACEUTICAL 2013 - Strategic Portfolio Planning for Global Drug Development ? approaches, techniques, tools

    View: 408

    Website https://compliance2go.com | Want to Edit it Edit Freely

    Category PHARMACEUTICAL 2013

    Deadline: May 29, 2013 | Date: May 29, 2013

    Venue/Country: Online, U.S.A

    Updated: 2013-05-03 17:54:21 (GMT+9)

    Call For Papers - CFP

    Why you should attend

    Portfolio planning is critical for developing company strategy.

    Due to complexity, advanced tools based on Decision Science need to be applied.

    Description of the topic

    Portfolio planning is critical for developing long-term company strategy. The goal is to select the “right” portfolio of internal and external drug development programs for funding, align company strategy and resources, and manage portfolio risk to buffer the organization against unfavorable events such as clinical trial failure, shifts in the marketplace or insufficient resources. Therefore, drug development portfolio should be balanced across strategic goals, value, resources and risk.

    Session goal is to provide comprehensive overview of innovative approaches, trends, best practices, and tools for portfolio management.

    Areas Covered In the Seminar

    Key Questions to Be Addressed:

    ? How to align strategic goals and available resources?

    ? What strategic risks should be prepared for?

    ? How to incorporate risk in portfolio planning?

    ? What tools could be used for portfolio planning, access and mitigate risk?

    ? How to simulate mitigation strategies?

    Who will benefit

    Portfolio managers

    Business analysts

    Business Development analysts

    Project managers

    Financial analysts

    Resource planners

    Executive management

    About Speaker

    Vladimir Shnaydman, Ph.D, ORBee Consulting, President (2004 ? current). The company’ focus is design and development of analytical tools and techniques for optimization of business solutions for life science industries. Company also provides consulting service, utilizing capabilities of developed tools and techniques.

    Vladimir has BS & MS Electrical Engineering & Computer Science, MS in Applied Mathematics & Operations Research, and Ph.D. in Engineering. He contributed to many industries such as biotechnology, computer networking, data storages, water resources planning and management, telecommunications, transportation, and others. Dr. Shnaydman published more than 50 papers. He is co-author of three books.

    Speaker : Dr Vladimir Shnaydman

    Product ID : F62325

    Schedule Date :

    Wednesday, May 29, 2013

    duration : 12:30 to 01:30 PM EDT

    https://compliance2go.com/index.php?option=com_training&speakerkey=62&productKey=251


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.